Stock quote - Summary

Shield Therapeutics
STX: 81.50 +4.00 ( +5.16 %) delayed: 16:57PM
Bid price 81.00 High price 82.00
Ask price 82.00 Low price 78.00
Open price 78.00 Spread 1.22%
Prev close 81.50 Volume 118,332

Shield Therapeutics - Share price charts

Intraday
Historic - 6 months

Advanced Shield Therapeutics charts >

Shield Therapeutics - Share price information
Name Shield Therapeutics Epic STX
Activities Shield Therapeutics plc is a de-risked commercial stage, pharmaceutical company delivering innovative specialty pharmaceuticals to address patients' unmet medical needs. The Company's clear purpose is to help its patients become people again, by enabling them to enjoy the things that make the difference in their everyday lives. The Group has a marketed product, Feraccru®, for the treatment of iron deficiency in adults which has exclusive IP rights until the mid-2030s. Feraccru is commercialised in the European Union by Norgine BV and the US Food and Drug Administration (FDA) is currently considering a New Drug Application (NDA), with a PDUFA (Prescription Drug User Fee Act) date of 27 July 2019. ISIN GB00BYV81293
Latest Share Price (p) 81.50 Net Gearing (%) -15.73
Market Capitalisation (pm) 90.53 Gross Gearing (%) 6.80
Shares in issue (m) 116.82 Debt Ratio 0.00
P/E Ratio -50.33 Debt-to-Equity Ratio 0.00
Total dividends per share (p) 0.00 Assets / Equity Ratio 1.07
Dividend Yield (%) 0.00 Price to book value 2.24
Dividend Cover 0.00 ROCE (%) -12.74
Earning per share (p) -1.54 EPS Growth (%) 90.94
52-week high / low (p) 83.00 / 15.10 DPS Growth (%) n/a
Shield Therapeutics - Broker views
Date Broker Recommendation Price Old target price New target price Notes
03 Apr Liberum Capital Buy 116.00 - Reiterates
03 Apr Peel Hunt Buy 88.00 - Reiterates
02 Apr Peel Hunt Buy 88.00 - Reiterates
15 Mar Peel Hunt Buy 88.00 - Reiterates
15 Mar Liberum Capital Buy 116.00 - Reiterates

More Shield Therapeutics broker views >

Shield Therapeutics - Director deals
Date Director Type Volume / Price Trade value
17 Apr 2019 Carl Sterritt Exercise 123,690 @ 1.50p £1,855.35
24 Sep 2018 Carl Sterritt Buy 88,235 @ 34.00p £29,999.90
05 Oct 2017 Carl Sterritt Buy 8,814 @ 100.00p £8,814.00

More Shield Therapeutics director deals >

Risk warning: Remember the price of shares can go down as well as up, and you are not guaranteed to get back the amount that you originally invested.
Click here to read the full warning.